Lataa...
Long-term Survival after Lapatinib Rechallenge in Isolated Brain Metastasis of HER2-positive Breast Cancer
Lapatinib is an effective drug in HER2-positive breast cancer. We present a case with successful treatment of lapatinib in brain metastasis of HER2+ breast cancer. Forty-eight years old woman was admitted our clinic with early breast cancer. In third years after adjuvant chemotherapy and trastuzumab...
Tallennettuna:
| Julkaisussa: | J Breast Health |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Turkish Federation of Breast Diseases Associations
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5351535/ https://ncbi.nlm.nih.gov/pubmed/28331691 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/tjbh.2014.2009 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|